Amit B. Shah

Amit B. Shah, listed as finance chief, appears in our data through filings on Oncotelic Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 20 November 2020 to 8 July 2021.

On the market, this insider has only ever bought: 3 purchases, €9,743 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.

Half of the purchases are above €3,216 and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 16 July 2021, reports a share grant in Oncotelic Therapeutics, Inc. The last purchase on record was published on 24 November 2020, which is 2,160 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.